2020
DOI: 10.1016/j.biomaterials.2020.120197
|View full text |Cite
|
Sign up to set email alerts
|

Biomimetic osteogenic peptide with mussel adhesion and osteoimmunomodulatory functions to ameliorate interfacial osseointegration under chronic inflammation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
93
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 125 publications
(95 citation statements)
references
References 65 publications
2
93
0
Order By: Relevance
“…Cell function is closely related to the immediate microenvironment and is influenced by many factors including inflammatory mediators that are critical in affecting regenerative outcomes [ 44 ]. Notably, failure to resolve the foreign body inflammatory response typically leads to granulation (formation of connective tissue) and fibrotic capsule formation around the implant resulting in impaired outcomes [ 45 ].…”
Section: Resultsmentioning
confidence: 99%
“…Cell function is closely related to the immediate microenvironment and is influenced by many factors including inflammatory mediators that are critical in affecting regenerative outcomes [ 44 ]. Notably, failure to resolve the foreign body inflammatory response typically leads to granulation (formation of connective tissue) and fibrotic capsule formation around the implant resulting in impaired outcomes [ 45 ].…”
Section: Resultsmentioning
confidence: 99%
“…Osteogenic peptide‐coated titanium implant demonstrated the potential to attenuate the inflammation response of M1 macrophages in vitro (RAW 264.7) and in vivo (rat model). [ 323 ] With osteoimmunomodulatory promotion on M2 macrophage polarization, the bioactive peptide coating could effectively inhibit osteoclastogenesis and ameliorate bone‐implant osseointegration in the presence of a chronic inflammation. Herein, we mainly focus on the biomaterial‐assisted targeted immunomodulation of monocytes/macrophages in tissue repair and regeneration immunotherapy, and some other representative studies/strategies reported are also summarized in Table 5 .…”
Section: Immunoengineering Applicationsmentioning
confidence: 99%
“…However, although we and others have demonstrated to control macrophage activities on the biomaterial surface, [ 39–41 ] a dynamic and smart “on–off” switch of macrophage‐mediated inflammation—in response to the regenerative signals—remains poorly accomplished. [ 26 ] For example, numerous excellent methods effectively stimulate macrophages to produce a desirable array of inflammatory signals (e.g., using macrophage‐stimulating coating); [ 42–44 ] or uncover the impact of surface geometry on macrophage phenotypic change (e.g., with micro‐/nanopatterning); [ 45–47 ] or induce a pro‐ to anti‐inflammatory change at arbitrary timepoints (e.g., through sequential release of cytokines). [ 48–50 ] Nevertheless, it remains an unmet goal to turn on and off the activities of inflammatory macrophages on implants in vivo in accordance with the healing progress.…”
Section: Introductionmentioning
confidence: 99%